This information was published on 2020-05-13T13:21:02 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2071909 (IR 1516747) |
| (220) |
12 Dec 2019
|
| (300) |
JP, 06 Nov 2019, 2019-141478
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Pharmaceutical preparations; pharmaceutical preparations for the prevention and treatment of cancer; biological preparations for medical purposes; regenerative preparations for medical purposes; cell preparations for the treatment of diseases and disorders; stem cells for medical purposes; cells for medical use. Class 40 Custom processing of human cells for others; custom processing of therapeutic cells for others; custom cultivation of human cells as medical materials for others; custom cultivation of human cells for others for medical purposes; custom manufacture of pharmaceuticals; custom manufacture of biopharmaceuticals. Class 42 Scientific and medical research and development; scientific services relating to the isolation and cultivation of human tissues and cells; analysis of human tissues and cells for medical research; cultivation of human cells; cultivation of cells for transplant taken from patients. Class 44 Medical services; provision of medical information; medical services relating to the removal, treatment and processing of human blood, human cells and stem cells; therapy services; medical treatment services; medical treatment services with cell preparations; medical treatment services with processed and cultivated cells; human tissue and cell bank services; analysis of human tissues and cells for medical treatment; collection, testing and preservation of human blood, human cells and stem cells. |
| (540) | MIPLYM |
| (550) | Word |
| (730) |
Otsuka Pharmaceutical Co., Ltd.
|
Find out more about publications on the About page.